Loading...
A study found 34% of mesh reconstruction patients experienced complications. Take our quick quiz to see if you qualify for compensation.
Surgical mesh has been used as an "internal bra" during breast reconstruction, augmentation, and lift procedures. However, the FDA has NOT approved surgical mesh for breast surgeries — meaning all such use is considered off-label.
Manufacturers including Allergan, C.R. Bard, and Integra Life Sciences have been accused of inadequate warnings, insufficient testing, and off-label marketing of these devices. A study published in The Breast journal found that 34% of 154 mesh reconstruction patients experienced complications, with 13% requiring surgical removal.
Breast mesh complications can be serious and life-altering. Common symptoms include:
As plastic surgeon Dr. Robert Schwartz notes: "The body could react to foreign mesh material, leading to infection serious enough to require removal, necessitating additional surgeries and longer recovery."
You may qualify for a breast mesh lawsuit if you:
Brands involved include AlloDerm, AlloMax, DuraSorb, FlexHD, GalaFLEX, Phasix, Strattice, and SurgiMend from manufacturers like Allergan/Lifecell, C.R. Bard, Integra Life Sciences, and MTF Biologics.
Time is limited — statutes of limitations vary by state. Contact us today for a free case evaluation.
There is NO upfront cost to using the attorneys and the consultation is 100% free of charge.